Signal transduction pathways involved in the stimulation of tissue type plasminogen activator by interleukin-1α and Porphyromonas gingivalis in human osteosarcoma cells

Journal of Periodontal Research

Volumn 41, Issue 5, 2006, Pages 374-380

  Chang, Yu Chao ^a,b   Ho, Yung Chuan ^b   Chou, Lin Shin Shen ^b   Chou, Ming Yung ^b   Huang, Fu Mei ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Casein zymography; Human osteosarcoma cells; Signal transduction pathway; Tissue type plasminogen activator

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASEIN; CHROMONE DERIVATIVE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; INTERLEUKIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHOLINE DERIVATIVE; NITRILE; PHOSPHATIDYLINOSITOL 3 KINASE; PYRIDINE DERIVATIVE; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BIOSYNTHESIS; CULTURE MEDIUM; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; METABOLISM; OSTEOSARCOMA; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BUTADIENES; CASEINS; CELL LINE, TUMOR; CHROMONES; CULTURE MEDIA, CONDITIONED; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; HUMANS; IMIDAZOLES; INTERLEUKIN-1ALPHA; MAP KINASE KINASE KINASES; MAP KINASE SIGNALING SYSTEM; MORPHOLINES; NITRILES; OSTEOSARCOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PORPHYROMONAS GINGIVALIS; PYRIDINES; TISSUE PLASMINOGEN ACTIVATOR; UP-REGULATION;

EID: 33748336488     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2005.00848.x     Document Type: Article

References (34)

1. de Vries C, Veerman H, Blasi F, Pannekoek H. Artificial exon shuffling between tissue-type plasminogen activator (t-PA) and urokinase (u-PA). A comparative study on the fibrinolytic properties of t-PA/u-PA hybrid proteins. Biochemistry 1988;27:2565-2572.
2. Mignatti P, Robbins E, Rifkin DB. Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 1986;47:487-498.
3. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophy Acta 1985;823:35-65.
4. Brown JM, Watanabe K, Cohen RL, Chambers DA. Molecular characterization of plasminogen activators in human gingival crevicular fluid. Arch Oral Biol 1995;40:839-845.
5. Xiao Y, Bunn CL, Bartold PM. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts. J Periodont Res 1998;33:17-26.
6. Kinnby B, Matsson L, Lecander I. The plasminogen activating system in gingival fluid from adults. An intraindividual study before and after treatment of gingivitis. Scand J Dent Res 1994;102:333-341.
7. Xia Y, Bunn CL, Bartold PM. Detection of tissue plasminogen activator and plasminogen activator inhibitor in gingival crevicular fluid from healthy, gingivitis and periodontitis patients. J Clin Periodontol 2002;27:149-156.
8. Kinnby B, Matsson L, Astodt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodont Res 1996;31:271-277.
9. Olofsson A, Maysson L, Kinnby B. Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets. J Periodont Res 2002;37:60-65.
10. Preiss DS, Meyle J. Interleukin-1β concentration of gingival crevicular fluid. J Periodontol 1994;65:423-428.
11. Stashenko P, Dewhirst FE, Peros WJ, Kent RL, Ago JM. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resportion. J Immunol 1987;138:164-168.
12. Chang YC, Yang SF, Huang FM, Tai KW, Hsieh YS. Induction of tissue plasminogen activator gene expression by proinflammatory cytokines in human pulp and gingival fibroblasts. J Endod 2003;29:114-117.
13. Bom-van Noorloos AA, vander Meer JWM, van de Gevel JS, Schepene E, van Steenbergen JJM, Burger EH. Bacteroides gingivalis stimulates bone resportion via interleukin-1 production by mononuclear cells. The relative role for B. gingivalis endotoxin. J Clin Periodontol 1990;17:409-413.
14. Yang SF, Hsieh YS, Huang FM, Yang LC, Chang YC. Effect of black-pigmented bacteria on the plasminogen/plasmin system in human pulp and osteoblastic cells. Oral Surg Oral Med Oral Pathol 2003;95:621-625.
15. Xiao Y, Bunn CL, Bartold PM. Effect of lipopolysaccharide from periodontal pathogens on the production of tissue plasminogen activator and plasminogen activator inhibitor 2 by human gingival fibroblasts. J Periodont Res 2001;36:25-31.
16. Vassalli JD, Sappino AP, Belim D. The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
17. Kruithof EKO, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator type 2. Blood 1995;86:4007-4024.
18. De Bart ACW, Quax PHA, Lowik CWGM, Verheijen JH. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. J Bone Miner Res 1995;10:1374-1384.
19. Daci E, Udagawa N, Martin TJ, Bouillon R, Carmeliet G. The role of the plasminogen system in bone resportion in vitro. J Bone Miner Res 1999;14:946-952.
20. Spence MJ, Streiff R, Day D, Ma Y. Oncostatin M induces tissue-type plasminogen activator and plasminogen activator inhibitor-1 in Calu-1 lung carcinoma cells. Cytokines 2002;18:26-34.
21. Ge X, Fu Y-M, Meadows GG. U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells. Cancer Lett 2002;179:133-140.
22. Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Terao T. Transforming growth factor-b1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 2004;279:8567-8576.
23. Chang YC, Chu SC, Yang SF, Hsieh YS, Yang LC, Huang FM. Examination of the signal transduction pathways leading to activation of gelatinolytic activity by interleukin-1α and Porphyromonas gingivalis in human osteosarcoma cells. J Periodont Res 2004;39:168-174.
24. Huang FM, Chang YC. Prevention of the epoxy resin based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants. Biomaterials 2005;26:1849-1855.
25. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem 1980;102:196-202.
26. Nelissen JMDT, Torensma R, Pluyter M et al. Molecular analysis of its hematopoiesis supporting osteoblastic cell line U2-OS. Exp Hematol 2000;28:422-432.
27. Mochan E, Armor L, Sporer R. Interleukin 1 stimulation of plasminogen activator production in cultured gingival fibroblasts. J Periodont Res 1988;23:28-32.
28. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40.
29. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002;296:1655-1657.
30. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993;28:500-510.
31. Chang YC, Yang SF, Hsieh YS. Regulation of matrix metalloproteinases-2 production by cytokines and pharmacological agents in human pulp cell cultures. J Endod 2001;27:679-682.
32. Chang YC, Lai CC, Yang SF, Chan Y, Hsieh YS. Stimulation of matrix metalloproteinases by black-pigmented Bacteroides in human pulp and periodontal ligament cell cultures. J Endod 2002;28:90-93.
33. Vassalii JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
34. Birkedal-Hansen H, More WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.